News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
123,408 Results
Type
Article (4209)
Company Profile (28)
Press Release (119171)
Section
Business (41864)
Career Advice (205)
Deals (6149)
Drug Delivery (12)
Drug Development (17329)
Employer Resources (18)
FDA (1467)
Job Trends (2768)
News (65800)
Policy (3631)
Tag
Academia (285)
Africa (136)
Alabama (12)
Allergies (9)
Alliances (11301)
ALS (4)
Alzheimer's disease (226)
Antibody-drug conjugate (ADC) (7)
Approvals (1455)
Arizona (13)
Artificial intelligence (6)
Asia (8216)
Australia (1902)
Bankruptcy (37)
Best Places to Work (2122)
Breast cancer (5)
C2C Services and Suppliers (4973)
California (269)
Canada (167)
Cancer (27)
Career advice (194)
CAR-T (8)
Cell therapy (15)
China (13)
Clinical research (13083)
Collaboration (13)
Compensation (6)
Connecticut (10)
COVID-19 (395)
Cystic fibrosis (14)
Diagnostics (617)
Diversity, equity & inclusion (8)
Earnings (11669)
Employer resources (18)
Europe (17635)
Events (23175)
Executive appointments (12)
FDA (1478)
Florida (19)
Funding (8)
Gene therapy (5)
GLP-1 (85)
Government (325)
Healthcare (1473)
Hotbed/Location (89093)
Idaho (10)
Illinois (60)
Indiana (23)
Infectious disease (395)
Inflammatory bowel disease (28)
Interviews (16)
IPO (2844)
Job creations (664)
Job search strategy (185)
Kansas (11)
Layoffs (29)
Legal (631)
Liver cancer (8)
Manufacturing (10)
Maryland (26)
Massachusetts (89)
Medical device (384)
Medtech (384)
Mergers & acquisitions (3286)
Metabolic disorders (21)
Neuroscience (241)
New Jersey (8)
New York (15)
NextGen Class of 2024 (812)
Non-profit (265)
North Carolina (39)
Obesity (16)
Opinion (32)
Parkinson's disease (7)
Patents (10)
Peanut (9)
Pennsylvania (11)
People (15764)
Phase I (5188)
Phase II (6237)
Phase III (3231)
Policy (10)
Postmarket research (209)
Preclinical (2228)
Rare diseases (17)
Real estate (1436)
Recruiting (10)
Regulatory (2761)
Reports (10)
Research institute (296)
Resumes & cover letters (18)
Schizophrenia (4)
South America (198)
Startups (979)
Texas (9)
United States (700)
Vaccines (22)
Washington State (60)
Webinars (5)
Weight loss (11)
Date
Today (13)
Last 7 days (116)
Last 30 days (480)
Last 365 days (9552)
2024 (5468)
2023 (9883)
2022 (11997)
2021 (12645)
2020 (9850)
2019 (6676)
2018 (5277)
2017 (6076)
2016 (5592)
2015 (6440)
2014 (4922)
2013 (4060)
2012 (4397)
2011 (4870)
2010 (4514)
123,408 Results for "novome biotechnologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Colorcon Ventures Invests in Novome Biotechnologies, an Engineered Microbial Therapy Company
Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Novome Biotechnologies, a clinical-stage company that develops engineered oral microbial therapies.
September 15, 2022
·
2 min read
Business
Novome Biotechnologies Appoints Bill McLeod as Chief Financial Officer
Novome Biotechnologies, Inc. today announced the appointment of Bill McLeod as Chief Financial Officer.
October 20, 2021
·
2 min read
Deals
Arbor Biotechnologies Announces Acquisition of Serendipity
Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, announced the acquisition of Serendipity Biosciences, a private biotechnology company focused on the discovery of unique gene editing technologies.
May 8, 2024
·
3 min read
BioMidwest
Anbio Biotechnology to Showcase at ADLM 2024 with Evolved In Vitro Diagnostic Solutions
Anbio Biotechnology (“Anbio”), a leading global diagnostic solution provider, is excited to announce its participation in the ADLM 2024 Clinical Lab Expo (formerly the AACC Clinical Lab Expo).
July 1, 2024
·
1 min read
Business
Novome Biotechnologies and Genentech Enter into a Strategic Collaboration to Develop Targets Against Inflammatory Bowel Disease
Novome Biotechnologies, Inc., a clinical-stage biotechnology company developing engineered cellular therapies for the gut, today announced a multi-year research collaboration and licensing agreement with Genentech.
November 10, 2021
·
3 min read
Drug Development
Novome Biotechnologies Reports Positive Results from a Phase 1 Study of NOV-001
Novome Biotechnologies, Inc., a clinical-stage biotechnology company developing engineered cellular therapies for the gut, today announced positive results from a Phase 1 study of orally-administered NOV-001 in healthy volunteers.
November 17, 2021
·
5 min read
Biotech Bay
Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit
Adverum Biotechnologies, Inc. today announced that Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies, will participate in a fireside chat at TD Cowen’s Genetic Medicines & RNA Summit on Friday, June 21, 2024 at 10:00 a.m. ET.
June 18, 2024
·
1 min read
BioMidwest
Battelle and Allonnia to Co-Host 2025 Bioremediation and Environmental Biotechnology Conference
Battelle is pleased to announce that it will co-host the Seventh International Symposium on Bioremediation and Environmental Biotechnology with Allonnia.
June 3, 2024
·
2 min read
Business
Novome Biotechnologies Appoints Dr. Lachy McLean as Chief Medical Officer
Novome Biotechnologies, Inc. today announced the appointment of Lachy McLean, MBChB, PhD, as Chief Medical Officer.
June 22, 2021
·
3 min read
BioForest
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation
Sana Biotechnology, Inc. today highlighted that Nature Biotechnology has published a paper titled “Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain.”
May 21, 2024
·
6 min read
1 of 12,341
Next
